Butterfly Network, Inc. ( (BFLY) ) has released its Q2 earnings. Here is a breakdown of the information Butterfly Network, Inc. presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Butterfly Network, Inc. is a digital health company revolutionizing medical imaging with its Ultrasound-on-Chip™ technology, offering portable ultrasound devices and software solutions to enhance healthcare delivery globally.
In its latest financial report, Butterfly Network announced a record-breaking second quarter for 2025, achieving the highest quarterly revenue and gross margins in the company’s history. The company reported a revenue of $23.4 million, marking a 9% year-over-year growth, and a gross margin of 64%.
Key highlights from the report include a significant reduction in cash usage to $7.1 million, the lowest ever for the company, and an improved Adjusted EBITDA loss of $6.2 million compared to $8.1 million in the previous year. Additionally, Butterfly Network revised its full-year revenue guidance and improved its Adjusted EBITDA guidance, projecting a revenue growth of approximately 15% for the fiscal year 2025.
Strategically, Butterfly Network is focusing on scaling its core business and exploring new revenue streams by leveraging existing technology. The upcoming launch of Compass AI software and advancements in their P5 chip and fourth-generation technology are expected to further solidify their leadership in the handheld ultrasound market.
Looking forward, Butterfly Network remains committed to innovation and expanding the adoption of its platform. The company aims to continue enhancing its product offerings and maximizing platform value, positioning itself for sustained growth in the evolving healthcare landscape.